Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDDDD.L Share News (DDDD)

  • There is currently no data for DDDD

DDDD.L News

4D Pharma taps John Beck as its new finance chief
1 Mar 2021

4D Pharma taps John Beck as its new finance chief

(Sharecast News) - Biotherapeutic pharmaceutical company 4D Pharma announced the appointment of John Beck as its chief financial officer and member of...

4D Pharma taps John Beck as its new finance chief
1 Mar 2021

4D Pharma taps John Beck as its new finance chief

(Sharecast News) - Biotherapeutic pharmaceutical company 4D Pharma announced the appointment of John Beck as its chief financial officer and member of...

IN BRIEF: 4D Pharma appoints former Ritter finance chief as own CFO
1 Mar 2021

IN BRIEF: 4D Pharma appoints former Ritter finance chief as own CFO

IN BRIEF: 4D Pharma appoints former Ritter finance chief as own CFO

4D Pharma Registration Statements Effective; Longevity Buy Progresses
26 Feb 2021

4D Pharma Registration Statements Effective; Longevity Buy Progresses

4D Pharma Registration Statements Effective; Longevity Buy Progresses

4D Pharma inks collaboration with Merck and Pfizer
8 Feb 2021

4D Pharma inks collaboration with Merck and Pfizer

(Sharecast News) - Biotherapeutics developer 4D Pharma announced a clinical trial collaboration and supply agreement with Merck and Pfizer on Monday, ...

4D Pharma, Merck And Pfizer Ink Trial Collaboration For Carcinoma Drug
8 Feb 2021

4D Pharma, Merck And Pfizer Ink Trial Collaboration For Carcinoma Drug

4D Pharma, Merck And Pfizer Ink Trial Collaboration For Carcinoma Drug

4D Pharma makes progress with MRx0518 development programme
3 Feb 2021

4D Pharma makes progress with MRx0518 development programme

(Sharecast News) - Biotherapeutic pharmaceutical company 4D Pharma announced progress on activities in its development programme for its lead immuno-o...

SMALL-CAP WINNERS & LOSERS: Dr Martens Puts Best Foot Forward
3 Feb 2021

SMALL-CAP WINNERS & LOSERS: Dr Martens Puts Best Foot Forward

SMALL-CAP WINNERS & LOSERS: Dr Martens Puts Best Foot Forward